CompletedNot Applicable

Procalcitonin Level as a Surrogate for Catheter-related Blood Stream Bacteremia Among Hemodialysis Patients

Saudi Arabia28 participantsStarted 2016-09-01

Plain-language summary

Hemodialysis patients frequently develop catheter-related blood stream bacteremia (CRBSI). Procalcitonin is a marker of sepsis in bacterial infection. this study for detection of its role as a surrogacy marker in CRBSI.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Hemodialysis patients with a dialysis catheter * signs suggestive of CRBSI: fever/chills or leucocytosis with no other site of infection. * Informed consent signed to be enrolled in the study Exclusion Criteria: * Patient with identified cause of fever other than CRBSI

What they're measuring

Procalcitonin Level

Timeframe: 2 minutes after start of fever/chills or other symptoms suggesting CRBSI

Trial details

NCT IDNCT03039777

SponsorBenha University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2017-02-28

View on ClinicalTrials.gov More Hemodialysis Catheter Infection trials